BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33086621)

  • 1. Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting.
    Kapitansky O; Karmon G; Sragovich S; Hadar A; Shahoha M; Jaljuli I; Bikovski L; Giladi E; Palovics R; Iram T; Gozes I
    Cells; 2020 Oct; 9(10):. PubMed ID: 33086621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and Sex-Dependent ADNP Regulation of Muscle Gene Expression Is Correlated with Motor Behavior: Possible Feedback Mechanism with PACAP.
    Kapitansky O; Sragovich S; Jaljuli I; Hadar A; Giladi E; Gozes I
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.
    Hacohen-Kleiman G; Sragovich S; Karmon G; Gao AYL; Grigg I; Pasmanik-Chor M; Le A; Korenková V; McKinney RA; Gozes I
    J Clin Invest; 2018 Nov; 128(11):4956-4969. PubMed ID: 30106381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.
    Sragovich S; Malishkevich A; Piontkewitz Y; Giladi E; Touloumi O; Lagoudaki R; Grigoriadis N; Gozes I
    Transl Psychiatry; 2019 Jan; 9(1):2. PubMed ID: 30664622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota changes associated with ADNP deficiencies: rapid indicators for NAP (CP201) treatment of the ADNP syndrome and beyond.
    Kapitansky O; Giladi E; Jaljuli I; Bereswill S; Heimesaat MM; Gozes I
    J Neural Transm (Vienna); 2020 Feb; 127(2):251-263. PubMed ID: 32072336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome.
    Gozes I; Shazman S
    Eur J Neurosci; 2023 Jul; 58(2):2641-2652. PubMed ID: 36669790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies.
    Karmon G; Sragovich S; Hacohen-Kleiman G; Ben-Horin-Hazak I; Kasparek P; Schuster B; Sedlacek R; Pasmanik-Chor M; Theotokis P; Touloumi O; Zoidou S; Huang L; Wu PY; Shi R; Kapitansky O; Lobyntseva A; Giladi E; Shapira G; Shomron N; Bereswill S; Heimesaat MM; Grigoriadis N; McKinney RA; Rubinstein M; Gozes I
    Biol Psychiatry; 2022 Jul; 92(1):81-95. PubMed ID: 34865853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
    Ivashko-Pachima Y; Gozes I
    Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
    Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse--a microtubule-deficient model of schizophrenia.
    Merenlender-Wagner A; Pikman R; Giladi E; Andrieux A; Gozes I
    Peptides; 2010 Jul; 31(7):1368-73. PubMed ID: 20417241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.
    Merenlender-Wagner A; Shemer Z; Touloumi O; Lagoudaki R; Giladi E; Andrieux A; Grigoriadis NC; Gozes I
    Autophagy; 2014; 10(12):2324-32. PubMed ID: 25484074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.
    Oz S; Kapitansky O; Ivashco-Pachima Y; Malishkevich A; Giladi E; Skalka N; Rosin-Arbesfeld R; Mittelman L; Segev O; Hirsch JA; Gozes I
    Mol Psychiatry; 2014 Oct; 19(10):1115-24. PubMed ID: 25178163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microtubules (tau) as an emerging therapeutic target: NAP (davunetide).
    Gozes I
    Curr Pharm Des; 2011; 17(31):3413-7. PubMed ID: 21902667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.
    Ivashko-Pachima Y; Ganaiem M; Ben-Horin-Hazak I; Lobyntseva A; Bellaiche N; Fischer I; Levy G; Sragovich S; Karmon G; Giladi E; Shazman S; Barak B; Gozes I
    Mol Psychiatry; 2022 Aug; 27(8):3316-3327. PubMed ID: 35538192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.
    Dresner E; Agam G; Gozes I
    Eur Neuropsychopharmacol; 2011 May; 21(5):355-61. PubMed ID: 20598862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADNP differentially interact with genes/proteins in correlation with aging: a novel marker for muscle aging.
    Kapitansky O; Gozes I
    Geroscience; 2019 Jun; 41(3):321-340. PubMed ID: 31264075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis.
    Mandel S; Rechavi G; Gozes I
    Dev Biol; 2007 Mar; 303(2):814-24. PubMed ID: 17222401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tauopathy in the young autistic brain: novel biomarker and therapeutic target.
    Grigg I; Ivashko-Pachima Y; Hait TA; Korenková V; Touloumi O; Lagoudaki R; Van Dijck A; Marusic Z; Anicic M; Vukovic J; Kooy RF; Grigoriadis N; Gozes I
    Transl Psychiatry; 2020 Jul; 10(1):228. PubMed ID: 32661233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
    Amram N; Hacohen-Kleiman G; Sragovich S; Malishkevich A; Katz J; Touloumi O; Lagoudaki R; Grigoriadis NC; Giladi E; Yeheskel A; Pasmanik-Chor M; Jouroukhin Y; Gozes I
    Mol Psychiatry; 2016 Oct; 21(10):1467-76. PubMed ID: 26782054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
    Gozes I
    Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.